Skip to main content
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 2010 Apr 24;59(8):1161–1162. doi: 10.1007/s00262-010-0854-9

Erratum to: Chronic alcohol consumption enhances myeloid-derived suppressor cells in B16BL6 melanoma-bearing mice

Hui Zhang 1, Gary G Meadows 1,
PMCID: PMC11030259

Erratum to: Cancer Immunol Immunother DOI 10.1007/s00262-010-0837-x

Unfortunately, Figs. 1 and 4 have some errors in the original publication. The symbols in Fig. 1c should read: Circle water-drinking mice. Square alcohol-consuming mice. For Fig. 4 the dot blot for Fig. 4a should be transposed with the dot blot in Fig. 4b.

The correct versions of figures are given below.

Fig. 1.

Fig. 1

 Effects of chronic alcohol consumption on CD44hiCD8+ T cells. a Dot plot showing the gated CD8+ T cells in splenocytes. b Histogram showing the CD44hi cells in the gated splenic CD8+ T cells of melanoma-bearing mice. c Percentage of CD8+CD44hi cells in CD8+ splenocytes from non-tumor injected mice (Cont) and melanoma-bearing mice at the indicated time points after tumor inoculation. Circle water-drinking mice. Square alcohol-consuming mice. Alcohol group different from water group, *P< 0.05, **P < 0.001. Each group contained ten mice and the results are representative to two separate experiments

Fig. 4.

Fig. 4

 Chronic alcohol consumption increases the percentages of MDSC in the PBL and of CD124+ cells in MDSC and CD11b+ cells. MDSC were determined 1 week after tumor inoculation. a Dot plot of CD11b+GR-1int MDSC in the PBL of water-drinking mice. b Dot plot of CD11b+Gr-1int MDSC in the PBL of alcohol-consuming mice, respectivley. c Percentage of CD11b+Gr-1int MDSC in the PBL. d Percentage of CD124+ cells in CD11b+Gr-1int MDSC cells. ETOH group significantly different from water group, *P < 0.05, **P < 0.001. ETOH Alcohol-consuming group, Water water-drinking group. Each group contained ten mice and the results are representative to two separate experiments

Footnotes

The online version of the original article can be found under doi:10.1007/s00262-010-0837-x.


Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES